Importantly, both clinical and animal studies support the notion that elevated aldosterone levels are a predictor for risk of coronary heart disease, stroke, and hypertension, while MR antagonists diminish CVD and cardiometabolic syndrome mortality [7,8,9,10]. Here, NR3C2 is linked to hypertensive disorder.